Perhaps Boonanza could give the company a call like he was early on after the IPO and report back to us. Perhaps he'd like to ask them if the directors are buying more at these low prices?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025